Atypical CAP Multiplex

Cat no. YSL-qPX-EC-ACAP-100

Atypical CAP Multiplex

Cat no. YSL-qPX-EC-ACAP-100

A multiplex qPCR kit for the detection of Atypical CAP

Lyme disease is a tick-borne illness characterized by flu-like symptoms, joint pain, and a distinctive bullseye rash. Caused by the bacterium Borrelia burgdorferi, it can affect both humans and animals, with a significant impact on the health sector. Early detection of Lyme disease is crucial to prevent the progression of the disease and potential long-term complications.

YouSeq's qPCR kit to detect Lyme disease allows for sensitive and specific identification of Borrelia burgdorferi in patient samples. Timely detection using this kit can lead to early treatment, reducing the risk of severe illness and long-term health consequences. This technology not only benefits individual patients but also has a broader impact on public health and healthcare systems.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target specific primer/probe mix, including endogenous control
qPCR MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer

Technical specification


Target Gene(s):MOMP gene,type IV secretion protein (IcmB) gene , internal transcribed spacer (ITS) region,Control gene
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)

Product variants


YSL-qPX-EC-ACAP-100 : Lyophilised version for ambient shipping
YS-qPX-EC-ACAP-100 : Frozen version for dry ice shipping

Pseudonyms

Flu; Influenza; H1N1; Swine flu; Seasonal flu; Orthomyxovirus; Flu virus

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources